These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 7304620)
21. Update on safe handling of hazardous drugs: the advice of experts. Power LA; Anderson RW; Cortopassi R; Gera JR; Lewis RM Am J Hosp Pharm; 1990 May; 47(5):1050-60. PubMed ID: 2186622 [TBL] [Abstract][Full Text] [Related]
22. Handling anticancer drugs: from hazard identification to risk management? Sorsa M; Hämeilä M; Järviluoma E Ann N Y Acad Sci; 2006 Sep; 1076():628-34. PubMed ID: 17119240 [TBL] [Abstract][Full Text] [Related]
24. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Valanis BG; Vollmer WM; Labuhn KT; Glass AG Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461 [TBL] [Abstract][Full Text] [Related]
25. Bureau of Human Prescription Drugs, Health Protection Branch issues guidelines for safe handling of cytotoxic agents. Besharah A Can Nurse; 1982 Jan; 78(1):46-7. PubMed ID: 6914907 [No Abstract] [Full Text] [Related]
26. Recommendations for handling cytotoxic drugs in hospitals. Am J Hosp Pharm; 1983 Dec; 40(12):2133-4. PubMed ID: 6660226 [No Abstract] [Full Text] [Related]
27. Handling antineoplastic-drug admixtures at cancer centers: practices and pharmacist attitudes. Gregoire RE; Segal R; Hale KM Am J Hosp Pharm; 1987 May; 44(5):1090-5. PubMed ID: 3605119 [TBL] [Abstract][Full Text] [Related]
28. [Guidelines for the health protection and safety of workers exposed to antineoplastic drugs]. Palazzo S; Bernardo G; Draicchio F; Lucchini R; Merlano M; Minguzzi M; Molinaro V; Scanni A; Sossai D; Villa L Med Lav; 1996; 87(3):255-64. PubMed ID: 8965737 [TBL] [Abstract][Full Text] [Related]
29. Reducing occupational exposure to potential carcinogens in hospitals. Zellmer WA Am J Hosp Pharm; 1981 Nov; 38(11):1679. PubMed ID: 7304618 [No Abstract] [Full Text] [Related]
30. [How hazardous are cytostatic agents to personnel?]. Johansson H Vardfacket; 1979 Jan; 3(1):10-6. PubMed ID: 253513 [No Abstract] [Full Text] [Related]
31. A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation. Baldo P; Bertola A; Basaglia G; Moneghini M; Sorio R; Zibardi E; Lazzarini R; De Paoli P J Eval Clin Pract; 2007 Apr; 13(2):265-71. PubMed ID: 17378874 [TBL] [Abstract][Full Text] [Related]
32. Protect yourself from the hazards of anticancer drugs. Gurwell A RN; 1983 Oct; 46(10):66, 67. PubMed ID: 6558799 [No Abstract] [Full Text] [Related]
33. Medical surveillance for antineoplastic-drug handlers. McDiarmid MA Am J Hosp Pharm; 1990 May; 47(5):1061-6. PubMed ID: 2337095 [TBL] [Abstract][Full Text] [Related]
34. Safe handling of cytotoxic drugs in the physician's office: a procedure manual model. Carmignani SS; Raymond GG Oncol Nurs Forum; 1997; 24(1 Suppl):41-8. PubMed ID: 9010864 [TBL] [Abstract][Full Text] [Related]
35. Reactions and interactions in handling anticancer drugs. D'Arcy PF Drug Intell Clin Pharm; 1983; 17(7-8):532-8. PubMed ID: 6872848 [TBL] [Abstract][Full Text] [Related]
36. Exposure of hospital pharmacists and nurses to antineoplastic agents. McDevitt JJ; Lees PS; McDiarmid MA J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505 [TBL] [Abstract][Full Text] [Related]
38. Studies on long-term, not short-term, effects of antineoplastic drug handling are needed. Slimowitz R; Mitrik LJ Am J Hosp Pharm; 1993 Sep; 50(9):1862-3. PubMed ID: 8135230 [No Abstract] [Full Text] [Related]
39. Antineoplastics: a safety hazard? Wilson JP; Solimando DA Am J Hosp Pharm; 1981 May; 38(5):624. PubMed ID: 7282687 [No Abstract] [Full Text] [Related]
40. Preparation of guidelines for the avoidance and treatment of extravasation due to antineoplastic drugs. Wolfe CA; Linkewich JA Hosp Pharm; 1987 Feb; 22(2):125-31. PubMed ID: 10280297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]